Integra Inks deal with Amerinet – Analyst Blog

Recently, Integra Lifesciences Holdings Corporation (IART) entered into a three-year deal with national health care group purchasing organization (GPO) Amerinet. As per the deal, Amerinet selected Integra as a supplier of Jarit surgical instruments. Both the companies aim to expand its foothold in the surgical instruments space.

Integra is a highly diversified medical products company that generates revenue through its three business segments: Integra NeuroSciences (neurosurgery and neurotrauma), Integra Orthopedics (burn, plastic and reconstructive surgery), and Integra Medical Instruments (basic general and specialty surgical instruments).

Jarit surgical instruments (acquired earlier in 2003) offer reusable surgical instruments used in virtually all surgical disciplines (laparoscopic, general, cardiovascular, neuro, gynecological, and orthopedic surgical specialties). Apart from Jarit, the Medical Instruments segment includes Miltex, Luxtec, and several other smaller product lines. For the 3 to 5 years horizon, Integra expects the Medical Instruments market to record a low-single digit growth.

Integra reported an 8% increase in net sales in the second quarter to $178.6 million with its segments –Orthopedics, NeuroSciences and Medical Instruments contributing 11.7%, 7.9% and 0.9%, respectively to the growth, driven by the increase in product sales across its segments.

Integra LifeSciences Holdings develops, manufactures and markets surgical implants and medical instruments and is a world leader in regenerative medicine. The company’s products are used primarily in neurosurgery, extremity reconstruction, orthopedics, and general surgery to treat millions of patients every year. Its direct competitors in the Medical Instruments & Supplies industry include Medtronic Inc. (MDT) and Stryker Corp. (SYK).